| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |